focus -WSS

focus

author：hotspot 2025-09-27 15:19:24 - browse：3238

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： 'Null' research findings aren't empty of meaning. Let's publish them

WSS

Sickle cell gene therapy cures need to be accessible in Africa

One Duchenne patient's bittersweet hope for new treatment

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Physicians aren't 'burning out.' They're suffering from moral injury

Chris Christie meets with Zelenskyy during Ukraine trip

Pharma showers House GOP doctor with campaign cash

explore

focus

leisure time

Bright Health sells Medicare Advantage business to Molina

The cancer stories no one wants to hear

Bright Health sells Medicare Advantage business to Molina

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Malaria cases in Florida and Texas: Here’s what you need to know

Heart disease in astronauts blamed on cosmic radiation

Malaria cases in Florida and Texas: Here’s what you need to know

How to ethically and practically extend health care to all

After affirmative action ruling, medical educators look to 'holistic review'

The debate over Covid

knowledge

Late stage cancers on the rise after pandemic delayed screenings

Grail's uphill battle for Medicare to cover its cancer screening test

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Study links childhood stress with decline in older age

FDA scientists endorse Pfizer/BioNTech Covid

hotspot

focus

focus

entertainment